From humble beginnings in 1983, Sun Pharma has grown into a leading specialty generic company worldwide and the No. 1 pharmaceutical company in India. In the U.S., we are amongst the leading specialty generic companies and are ranked No. 2 in generic dermatology by prescriptions. We have a presence in 80 countries across emerging markets, with Brazil, Mexico, Russia, Romania, and South Africa being some of the key markets. We maintain a strong footprint across Western Europe, Canada, Australia, New Zealand, Israel and Japan.
Recent Posts
- Sun Pharma Establishes Endowed Professorship at Mount Sinai to Advance Dermatologic Care
- Sun Pharma and LIB Therapeutics announce global licensing agreement for Lerodalcibep
- Sun Pharma Launches CTaro-Methylphenidate ER, the First and Only Bioequivalent to Concerta® with an Osmotic Delivery System
- Sun Pharma reports Q1FY27 results
- Sun Pharma receives approval to manufacture and market semaglutide in Brazil
Recent Comments